Evidence map›Paper›PMID 42534709›Full record

ArticleEJHaem2026

Resolution of Paraneoplastic Cutaneous Angioendotheliomatosis After CAR T-Cell Therapy in TP53-Deleted CLL: A Case Report.

Feras Alfraih, Mostafa F Mohammed Saleh, David Li, Razan Mohty, Mohamed Kharfan-Dabaja

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Feras AlfraihAdult Hematology, Stem Cell Transplant and Cellular Therapy Department Oncology Center King Faisal Specialist Hospital and Research Center Riyadh Saudi Arabia.
Mostafa F Mohammed SalehAdult Hematology, Stem Cell Transplant and Cellular Therapy Department Oncology Center King Faisal Specialist Hospital and Research Center Riyadh Saudi Arabia.
David LiPathology and Laboratory Medicine Mayo Clinic Jacksonville Florida USA.
Razan MohtyDivision of Hematology-Oncology University of Alabama Birmingham Alabama USA.
Mohamed Kharfan-DabajaBlood and Marrow Transplantation Program Division of Hematology-Oncology Mayo Clinic Jacksonville Florida USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous manifestations of chronic lymphocytic leukemia (CLL) are heterogeneous and may result from leukemic infiltration, secondary malignancies, infectious complications, or reactive inflammatory processes. Reactive angioendotheliomatosis (RAE) is a rare vascular proliferation that has only infrequently been reported in association with hematologic malignancies. We describe a 58-year-old man with high-risk relapsed/refractory CLL harboring Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.

Indexed as

CAR T‐cell therapycase reportchronic lymphocytic leukemiacutaneous lesionsTP53 mutation

Identifiers

PMID42534709
PMCPMC13421918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.